Vimpat

UCB Patient Assistance Program Patient Guide: How to Get Vimpat (lacosamide) at Low or No Cost

Vimpat (lacosamide) is an anticonvulsant medication used to treat partial-onset seizures in patients with epilepsy, either alone or with other seizure medicines. The UCB Patient Assistance Program helps eligible uninsured or underinsured patients in the United States get Vimpat for free if they meet income and other requirements.

About Vimpat (Lacosamide)

Vimpat is a prescription drug that works by slowing down impulses in the brain that cause seizures. It's available as tablets, oral solution, or intravenous injection. Common side effects include dizziness, headache, nausea, and double vision. Always take it exactly as prescribed by your doctor, and never stop suddenly without medical advice, as this could worsen seizures. This program provides Vimpat at no cost to qualified patients, easing the financial burden of this important epilepsy treatment.

Who Qualifies for the Program?

The UCB Patient Assistance Program is designed for patients facing financial hardship. Key eligibility criteria include:

• Residing in the United States, District of Columbia, or U.S. Territories.
• Being uninsured (no prescription coverage) or underinsured (insurance doesn't cover the full cost, or you have significant out-of-pocket expenses).
• Having a valid prescription for Vimpat from a U.S.-licensed healthcare provider.
• Meeting income guidelines, typically up to 300-500% of the Federal Poverty Level (FPL) based on household size—exact thresholds aren't publicly fixed but are verified during application.[7][8]
• For Vimpat applicants, providing a valid driver's license or government-issued ID.[2]

Patients on Medicare Part D may qualify if they experience financial hardship despite coverage.[1][7]

Income Eligibility Breakdown

Income limits are based on household size and Federal Poverty Level (FPL). While specific percentages vary (often 300-500% FPL), you must submit proof of income for verification. Use the table below as a general guide (2026 FPL estimates; confirm current levels via program contact).

Notes: Add ~$16,140 per additional person for 300% FPL; ~$26,900 for 500% FPL. Exact eligibility determined by UCB—contact them for your situation. Proof like tax returns or pay stubs required.[7][8]

Insurance Requirements

• Uninsured patients: No prescription insurance at all qualify easily.
• Underinsured: Limited coverage, high copays, or denials for Vimpat. Medicare Part D patients may qualify with proof of hardship.
• Include copies of insurance cards if applicable. You'll confirm status verbally.[1][2][7]
• Commercial insurance or Medicaid details must be provided; program coordinates benefits.

Step-by-Step Application Process

1. Check Eligibility: Review criteria above. Call (866) 395-8366 or UCBCares at 1-844-599-2273 if unsure.[1][5]
2. Gather Documents:
   • Proof of income (tax return, W-2, pay stubs—must be signed).[2]
   • Proof of residency (utility bill, etc.).
   • Valid Vimpat prescription.
   • Copy of insurance cards (front/back) if any.
   • Driver's license or government ID for Vimpat.[2]
3. Complete Application: Download from ucb-usa.com or use online portal at ucb-pap.enrollsource.com. Patient fills sections 1-2 (personal/income info); doctor completes section 3 and signs.[1][2][4]
4. Submit: Mail, fax, or online. Multiple methods available (phone support at (866) 395-8366).[1]
5. Verification: UCB reviews and may call for insurance confirmation. All info subject to verification.[1]

Timeline and Delivery

• Processing Time: Typically 2-4 weeks after complete submission.[1][2]
• Once approved, Vimpat is shipped free to your home (not doctor's office).[1]
• Approval lasts up to 12 months; reauthorization required annually with new application.[7]

Alternatives if Denied

• Contact UCBCares at 1-844-599-2273 for other UCB resources or copay help.[1][5]
• Explore third-party services like Simplefill (877-386-0206) for application help.[7]
• Check rxassist.org or rxhope.com for similar programs.[8][9]
• State assistance, generic options, or epilepsy foundations (e.g., Epilepsy Foundation PAPs).
• No biosimilars for Vimpat currently.

Important Disclaimer

This guide is for informational purposes only and based on publicly available data as of 2026. Eligibility, terms, and availability can change—always verify directly with UCB at (866) 395-8366 or ucb-usa.com. Not medical advice; consult your doctor for Vimpat suitability. UCB may deny applications or request more info. By applying, you authorize verification of info provided.[1][2] (Word count: 942)